Luís Querol
Impact in
- Neurology top 0.1%
- Peripheral Neuropathies and Disorders
- Myasthenia Gravis and Thymoma
- Autoimmune Neurological Disorders and Treatments
- Long-Term Effects of COVID-19
-
- Multiple Sclerosis Research Studies
Papers in
- Neurology 134
- Peripheral Neuropathies and Disorders 103
- Myasthenia Gravis and Thymoma 22
- Autoimmune Neurological Disorders and Treatments 9
-
- Multiple Sclerosis Research Studies 18
- Co-authors
- Isabel Illa (34 shared papers)Ricard Rojas‐García (27 shared papers)Jordi Díaz‐Manera (23 shared papers)Eduard Gallardo (20 shared papers)Jérôme Joël Devaux (7 shared papers)Gisela Nogales‐Gadea (6 shared papers)Xavier Suárez‐Calvet (6 shared papers)Eugenia Martínez‐Hernández (7 shared papers)
- Journals
- Neurology (19 papers)Neurology Neuroimmunology & Neuroinflammation (18 papers)Journal of the Peripheral Nervous System (14 papers)European Journal of Neurology (10 papers)Brain (8 papers)
- Partner nations
- SpainNetherlandsUnited States
In The Last Decade
Luís Querol
162 papers receiving 7.9k citations
Luís Querol's Hit Papers
Peers
Comparison fields: 5 of 112
- Neurology 6k
- Pathology and Forensic Medicine 756
- Immunology 243
- Cellular and Molecular Neuroscience 197
- Rheumatology 132
Countries citing papers authored by Luís Querol
This map shows the geographic impact of Luís Querol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luís Querol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luís Querol more than expected).
Fields of papers citing papers by Luís Querol
This network shows the impact of papers produced by Luís Querol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luís Querol. The network helps show where Luís Querol may publish in the future.
Co-authors
The 25 scholars most cited alongside Luís Querol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 169 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study Hit paper breakdown → | 2017 | 632 |
| 2 | Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis Hit paper breakdown → | 2018 | 480 |
| 3 | European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision Hit paper breakdown → | 2021 | 339 |
| 4 | European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision Hit paper breakdown → | 2021 | 313 |
| 5 | 2014 | 311 | |
| 6 | 2012 | 292 | |
| 7 | 2012 | 276 | |
| 8 | Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study Hit paper breakdown → | 2020 | 261 |
| 9 | 2015 | 225 | |
| 10 | 2018 | 224 | |
| 11 | 2017 | 188 | |
| 12 | Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study Hit paper breakdown → | 2023 | 188 |
| 13 | 2017 | 179 | |
| 14 | 2015 | 140 | |
| 15 | 2016 | 135 | |
| 16 | 2016 | 132 | |
| 17 | 2020 | 132 | |
| 18 | 2014 | 109 | |
| 19 | European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome Hit paper breakdown → | 2023 | 103 |
| 20 | 2014 | 97 |
About Luís Querol
Luís Querol is a scholar working on Neurology, Pathology and Forensic Medicine, Cellular and Molecular Neuroscience, Epidemiology and Physiology, having authored 169 papers that have together received 8.1k indexed citations. Recurring topics across this work include Peripheral Neuropathies and Disorders (103 papers), Myasthenia Gravis and Thymoma (22 papers), Multiple Sclerosis Research Studies (18 papers), Autoimmune Neurological Disorders and Treatments (9 papers), Lysosomal Storage Disorders Research (3 papers), Hereditary Neurological Disorders (3 papers), Inflammatory Myopathies and Dermatomyositis (3 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Neurology (6k citations), Pathology and Forensic Medicine (756 citations), Immunology (243 citations), Cellular and Molecular Neuroscience (197 citations) and Rheumatology (132 citations). Luís Querol has collaborated with scholars based in Spain, Netherlands and United States. Frequent co-authors include Isabel Illa, Ricard Rojas‐García, Jordi Díaz‐Manera, Eduard Gallardo, Jérôme Joël Devaux, Gisela Nogales‐Gadea, Xavier Suárez‐Calvet, Eugenia Martínez‐Hernández, Josep O. Dalmau and Pieter A. van Doorn. Their work appears in journals such as Neurology, Neurology Neuroimmunology & Neuroinflammation, Journal of the Peripheral Nervous System, European Journal of Neurology and Brain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.